Bortezomib-associated cutaneous vasculitis.
Garcia-Navarro
X
X
Puig
L
L
Fernández-Figueras
M T
MT
Dalmau
J
J
Roe
E
E
Alomar
A
A
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000009:adverse effects; D011719:Pyrazines / Q000009:adverse effects*; D017445:Skin Diseases, Vascular / Q000139:chemically induced*; D014657:Vasculitis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib